- Home
- GALT vs GRABW Comparison
GALT vs GRABW Comparison
Compare GALT & GRABW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- GRABW
- Stock Information
- Founded
- GALT 2000
- GRABW N/A
- Country
- GALT United States
- GRABW Singapore
- Employees
- GALT N/A
- GRABW 10604
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- GRABW Business Services
- Sector
- GALT Health Care
- GRABW Consumer Discretionary
- Exchange
- GALT Nasdaq
- GRABW Nasdaq
- Market Cap
- GALT 147.8M
- GRABW N/A
- IPO Year
- GALT N/A
- GRABW N/A
- Fundamental
- Price
- GALT $1.04
- GRABW $0.42
- Analyst Decision
- GALT Strong Buy
- GRABW
- Analyst Count
- GALT 1
- GRABW 0
- Target Price
- GALT $11.00
- GRABW N/A
- AVG Volume (30 Days)
- GALT 1.1M
- GRABW N/A
- Earning Date
- GALT 11-13-2024
- GRABW N/A
- Dividend Yield
- GALT N/A
- GRABW N/A
- EPS Growth
- GALT N/A
- GRABW N/A
- EPS
- GALT N/A
- GRABW N/A
- Revenue
- GALT N/A
- GRABW N/A
- Revenue This Year
- GALT N/A
- GRABW N/A
- Revenue Next Year
- GALT N/A
- GRABW N/A
- P/E Ratio
- GALT N/A
- GRABW N/A
- Revenue Growth
- GALT N/A
- GRABW N/A
- 52 Week Low
- GALT $0.73
- GRABW N/A
- 52 Week High
- GALT $4.27
- GRABW N/A
- Technical
- Relative Strength Index (RSI)
- GALT 20.80
- GRABW 44.46
- Support Level
- GALT $1.80
- GRABW $0.49
- Resistance Level
- GALT $2.36
- GRABW $0.54
- Average True Range (ATR)
- GALT 0.27
- GRABW 0.05
- MACD
- GALT -0.08
- GRABW -0.02
- Stochastic Oscillator
- GALT 15.07
- GRABW 11.70
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.